Why Are Sickle Cell Patients Predisposed to Renal Medullary Carcinoma?
What can predispose sickle cell patients to renal medullary carcinoma (RMC)? Watch as expert Dr. Kimryn Rathmell shares situations that can predispose those with sickle cell to RMC and symptoms that can signal RMC.
Ensuring Pneumococcal Immunity in Sickle Cell Disease Children
The genetic condition of sickle cell disease (SCD) results when sickle cell genes are inherited from each parent. We connected with Dr. Seethal Jacob about a study on maintaining an immune response against pneumococcal bacteria in children with SCD.
High-Intensity Exercise and Renal Medullary Carcinoma in Those With Sickle Cell Trait
As the most commonly occurring blood disorder in the world, sickle cell trait primarily impacts those in the BIPOC community with African ancestry. We connected with Dr. Pavlos Msaouel about a study on high-intensity exercise in those with sickle cell trait.
Empowering Communities Through Digital Health Equity
Blood transfusions, organ transplants, and bone marrow transplants can be detrimental situations for any person who needs one. But what special considerations are there for those who are of BIPOC and mixed races?
International Sickle Cell Expert Shares Early Devotion to Health Disparities
Dr. Andrew Campbell shares the reasons that drive him to help people with sickle cell disease in this Heart Behind the White Coat (HBWC) program.
What Advice Does a Sickle Cell Expert Have for Medical Students?
Dr. Andrew Campbell shares his key points for medical students to consider and describes the traits it takes to be a provider of sickle cell care in this Heart Behind the White Coat (HBWC) program.
How Can Sickle Cell Disease Education Improve Health Outcomes?
Dr. Alexander Glaros shares why sickle cell disease education and research are so important to achieve health equity for underserved patients in this Heart Behind the White Coat (HBWC) program.
How Can Others Improve Health Outcomes for Sickle Cell Disease?
Sickle cell disease expert Dr. Alexander Glaros shares why passion is important for disease experts and the differences in health equities for adult and pediatric patients.
Sickle Cell: A Disease of Healthcare Disparities
We’ve had the opportunity to speak with Dr. Andrew Campbell, director of the Consortium for the Advancement of Sickle Cell Research (CASiRe), to discuss the recent publication of two important research papers, and to go into greater depth about the systemic barriers that prevent access to care for sickle cell patients across the globe.
Microcosms of Injustice Found Throughout Sickle Cell Disease
Dr. Andrew Campbell presents an example of a patient who almost died because she was not heard. In sickle cell patients, pain episodes can precede major complications that need treatment.
Is Sickle Cell Disease a Defense Against COVID-19?
Dr. Pavlos Msaouel answers questions from the Sickle Cell community, including on the relationship between COVID-19 and hydroxychloroquine?
How Can Providers Combat Inequities in the Care of Renal Medullary Carcinoma Patients?
Dr. Pavlos Msaouel tackles the question of how providers can combat inequities in the care of renal medullary carcinoma (RMC) patients.
Can Patients and Providers Eliminate Health Inequities in Treating Sickle Cell Disease?
Dr. Andrew Campbell shares how communities, patients, and providers can eliminate health inequities in sickle cell disease (SCD).
Are Sickle Cell Disease Patients More Susceptible to Renal Medullary Carcinoma?
Are sickle cell disease patients more at risk for developing renal medullary carcinoma? Watch as Dr. Pavlos Msaouel explains.
What Can Communities Do to Eliminate Disparities in Sickle Cell Disease?
Disparities in SCD can be eliminated by increasing knowledge of the disease throughout the whole community. Watch as Dr. Ify Osunkwo explains.
Will New Sickle Cell Disease Drugs Transform Quality of Care for Patients?
Dr. Andrew Campbell of Children's National shares his excitement around the increasing treatment arsenal in sickle cell disease and how it might change care.
What Is Your Sickle Cell Disease Management Plan?
Dr. Ify Osunkwo of Levine Cancer Institute/Atrium Health discusses what patients can expect related to sickle cell disease management in the near future.
Multinational CASiRe - Will Emerging Tools Harmonize Treatment for Sickle Cell Disease Patients?
Noted pediatric hematologist, Dr. Raffaella Colombatti provides perspective on her multinational CASiRe study (Consortium for the Advancement of Sickle Cell Research) of sickle cell disease in Europe.
Multinational CASiRe - Will Sickle Cell Disease Clinicians & Trials Consider Diverse Populations?
Renowned expert, Dr. Andrew Campbell, Director of the CASiRe Consortium, provides an update on an international study of nearly 900 sickle cell disease patients from Ghana, Italy, the UK, and US.
What Novel Tools Are Being Used to Treat Sickle Cell Disease?
Dr. Ify Osunkwo of Levine Cancer Institute/Atrium Health discusses new therapeutic tools used to treat sickle cell disease (SCD) over the last few years and how they will impact patient quality of life.